Skip to main content
Retatrutide Research

Lilly PR — TRIUMPH-4 Results 2025

Lilly Press Release

Eli Lilly

Summary

28.7% weight loss at 68 weeks

Study Details
Study Design

Phase 3 results announcement

Indication

Obesity

Intervention

Retatrutide

Species

Human

Risk of Bias Assessment

Press release only

Tags
SourcePress ReleaseRetatrutideTriumph 4
Metrics
Citations
0
Evidence QualityN/A
Related PeptideRetatrutide8 papers